Hemophilia Drugs Market 2019 Analysis, Exhibit 6.0% CAGR and Remarkable Growth Rate forecast till 2025

Hemophilia Drugs Market is projected for better diagnosis because patients with hemophilia suffer from an abnormal blood loss and this weakens their blood clotting process, Hemophilia Drugs Industry exhibit a 6.0% & strong growth in the coming years

pune, india - May 16, 2019 /MarketersMedia/ —

The Global Hemophilia Drugs Market covered a value of US$ 9875.4 Mn in the year 2017 and is anticipated to reach US$ 15830.3 Mn by 2025. Furthermore, the global market for hemodialysis is expected to report a CAGR of 6.0% during the forecast period. The above information was published in a report, titled “Hemophilia Drugs Market Size, Share and Global Trend by Disease Indication (Hemophilia A, B & C), Therapy Type (Recombinant Therapy, Plasma therapy & Others), Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2025.”

The rising prevalence of severe diseases is one of the major concerns in the healthcare industry. Among these disorders, patients with hemophilia suffer from an abnormal blood loss and this weakens their blood clotting process. Companies are introducing novel hemophilia drugs and therapies to fulfil the unmet needs of patients and maintain their quality of life. A lead analyst at Fortune Business Insights said, “Companies are building expansion strategies to develop new hemophilia drugs so as to offer better diagnosis.”

Among disease indications, hemophilia A is projected to exhibit a strong growth in the coming years. In addition to this, this segment covered a share of 85% in the global hemophilia drugs market in 2017. This is mainly attributable to the rising pool patients suffering from hemophilia across the world. Also, rising initiatives at developing and commercializing new products for the effective treatment of hemophilia is driving this segment’s growth. Following hemophilia A, hemophilia B drugs are also expected to grow at a considerable rate in the years to come.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/hemophilia-drugs-market-100068

Asia Pacific to Grow at a Rapid Pace with Rising Number of Hemophilia Patients

North America is projected to emerge dominant in the global hemophilia drugs market during the forecast period. This is mainly ascribable to the rising prevalence of hemophilia A and B, especially in countries such as Canada and the U.S. Moreover, in 2017, North America market for hemophilia drugs covered a value of US$ 3,684.7 Mn. Trailing North America, Europe is the second-leading region in the global hemophilia drugs market. The growth in this region is attributable to the rising healthcare budgets by governments and initiatives by governments to promote hemophilia drugs treatment. On the other hand, the hemophilia drugs market in Asia Pacific is likely to expand at a higher CAGR between 2017 and 2025 on account of rising number of patients suffering from hemophilia especially in countries such as China and India.

Rising Awareness About Hemophilia to Augment the Demand

The primary factor augmenting the hemophilia drugs market is the recent developments in hemophilia treatment. A lead analyst at Fortune Business Insights said “Several new drugs are expected to enter the global market in the coming years.” Also, hemophilia surgical management is gaining traction on account of increasing awareness about hemophilia across the world. Moreover, governments are planning to conduct awareness initiatives to spread knowledge regarding the use of hemophilia treatment and drugs This, in turn, is expected to drive the hemophilia drugs market over the next few years. The genetic evolution is leading to rising incidences of bleeding disorders across the world. This will further lead to hemophilia drug development in the next few years to come. As per the study conducted by the National Hemophilia Foundation or NHF in 2015, about 1% of the U.S. population is likely to suffer from a disease called von Willebrand, hence rising the need for hemophilia treatment drugs.

Pfizer Introduced Gene Therapy to Address Unmet Patient’s Needs

Some of the leading players presently operating in the global market for hemophilia drugs are Grifols SA, Bioverativ Inc., FERRING LÄKEMEDEL AB, Aptevo Therapeutics, Hoffmann-La Roche Ltd, Novo Nordisk, Pfizer, Inc. and CSL Behring. In 2018, companies such as Novo Nordisk, Takeda Pharmaceutical Company Ltd., and F. Hoffmann-La Roche Ltd covered more than half of the share in the global hemodialysis market as per revenue. In 2017, Pfizer, Inc. collaborated with Sangamo Therapeutics, Inc. to commercialize and develop gene therapy programs. The aim was to utilize these programs for Hemophilia A drugs.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/hemophilia-drugs-market-100068

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India
Phone: 1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/hemophilia-drugs-market-2019-analysis-exhibit-60-cagr-and-remarkable-growth-rate-forecast-till-2025/513243

Source: MarketersMedia

Release ID: 513243

Latest News

Thai king celebrates coronation with spectacular parade

May 24, 2019

BANGKOK — Thailand's newly crowned King Maha Vajiralongkorn made a spectacular public appearance in front of his countrymen Sunday, carried atop a golden palanquin by soldiers in ancient fighting uniforms in a procession through Bangkok's historic quarter. Hundreds of other soldiers marched in front, behind and alongside the palanquin in scorching heat as the procession set off from Bangkok's Grand Palace just after 5 p.m. with a marching band setting the pace. Also taking part in the slow parade were the prime minister and other senior officials in the military government as well as the king's wife, Queen Suthida, and...

Family says Brazilian model who died on catwalk was healthy

May 24, 2019

RIO DE JANEIRO — Relatives of a model who died on the catwalk during Sao Paulo Fashion Week said the man was apparently healthy, denying rumors spreading on the internet. Officials have not released an autopsy report on what killed Tales Soares, who was being buried on Monday, but his mother and sister denied that the 26 year-old model suffered health problems such as epilepsy or anorexia or that he used drugs. "He always had good health and looked after himself with periodic (medical) exams, however fatalities happen and his time had come," his mother, Heloisa Cotta, wrote on Facebook...

Model in Sao Paulo dies after taking ill on catwalk

May 24, 2019

RIO DE JANEIRO — A model participating in Sao Paulo's Fashion Week has died after getting sick and falling on the catwalk. A statement from organizers said Tales Soares took ill Saturday while in a parade of fashion brand Ocksa. A medical team attended to him on the catwalk and Soares was later taken to a hospital, where he was pronounced dead. The statement did not provide more details. Daily Folha de S. Paulo reported that Soares tripped on his shoelace and fell. According to the paper, people in the crowd initially thought his fall was part of a performance....

Aussie doctors bestowed Thai royal honors for cave rescue

May 24, 2019

BANGKOK — Two Australian doctors were given royal honors in Thailand on Friday for helping rescue a boys soccer team from a flooded cave and said they are looking forward to a reunion with the youngsters they helped save. Richard Harris and Craig Challen were given the award at a ceremony presided over by Thai Prime Minister Prayuth Chan-ocha. Four Australian officials involved with the rescue effort were also honored. Both highly skilled divers, the doctors played key roles in rescuing members of the Wild Boars soccer team and their coach from the cave complex in Chiang Rai province last...

Brazil to auction oil camps despite environmental warnings

May 24, 2019

RIO DE JANEIRO — The administration of President Jair Bolsonaro plans to auction seven offshore oil fields in the northeast despite contrary advice from analysts of Brazil's main environmental body, according to documents obtained by the Associated Press. Environmentalists say it's the latest example of how Bolsonaro, who campaigned on promises to revive Latin America's largest economy by cutting red tape, is pushing aside warnings and scientific evidence in the name of progress. It comes at a time when Brazil, one of the world's largest oil producers and energy consumers, is moving toward the privatization of several industries, including offshore...

Diver Haven is brought to you by a team of tech-savvy diving enthusiasts. Diver of all walks of life be it recreational to professional, scuba or freedivers are always welcome.

Contact us: sales[at]diverhaven.com